Select Publications
Journal articles
2024, 'Effect of a Smartphone App (S-Check) on Actual and Intended Help-Seeking and Motivation to Change Methamphetamine Use Among Adult Consumers of Methamphetamine in Australia: Randomized Waitlist-Controlled Trial', JMIR mHealth and uHealth, 12, http://dx.doi.org/10.2196/55663
,2023, '“There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia', BMC Health Services Research, 23, pp. 162, http://dx.doi.org/10.1186/s12913-023-09125-z
,2023, 'Methamphetamine and emerging drugs of concern: A training needs analysis of Australian alcohol and other drug helplines', Drug and Alcohol Review, 42, pp. 1744 - 1753, http://dx.doi.org/10.1111/dar.13719
,2022, 'Integrating healthcare services for people experiencing homelessness in Australia: key issues and research principles.', Integr Healthc J, 4, pp. e000065, http://dx.doi.org/10.1136/ihj-2020-000065
,2021, 'One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review', International Journal of Infectious Diseases, 112, pp. 63 - 65, http://dx.doi.org/10.1016/j.ijid.2021.09.012
,2021, 'Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: A phase-2 dose-escalation study', BMJ Open, 11, pp. e044696, http://dx.doi.org/10.1136/bmjopen-2020-044696
,2019, 'Homelessness, health and the policy process: A literature review', Health Policy, 123, pp. 1125 - 1132, http://dx.doi.org/10.1016/j.healthpol.2019.08.011
,2019, 'A systems change intervention for nurse-led smoking cessation care in hospitals', Collegian, 26, pp. 235 - 241, http://dx.doi.org/10.1016/j.colegn.2018.07.007
,2018, 'LiMA: A study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence', BMJ Open, 8, http://dx.doi.org/10.1136/bmjopen-2017-020723
,2018, 'Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studies', International Journal of Drug Policy, 55, pp. 165 - 168, http://dx.doi.org/10.1016/j.drugpo.2018.03.020
,2018, 'A managed alcohol program in Sydney, Australia: Acceptability, cost-savings and non-beverage alcohol use', Drug and Alcohol Review, 37, pp. S184 - S194, http://dx.doi.org/10.1111/dar.12702
,2016, 'Study protocol: A dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence', BMC Psychiatry, 16, http://dx.doi.org/10.1186/s12888-016-1141-x
,2016, 'LISDEX I: DOSE-ESCALATING, PHASE-2 STUDY OF ORAL LISDEXAMFETAMINE IN ADULTS WITH METHAMPHETAMINE DEPENDENCE', DRUG AND ALCOHOL REVIEW, 35, pp. 36 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Papers
2022, 'A qualitative exploration of client and healthcare provider perspectives on why people who inject drugs with injecting-related infections discharge against medical advice', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S43 - S44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Presentations
2024, 'Emerging drugs of concern - Prompt Response Network update', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=3141s
,2023, 'Innovations beyond BC: Lisdexamfetamine for the treatment of methamphetamine use disorder and withdrawal', presented at The 5th Annual BC Substance Use Conference, Vancouver, Canada, 20 April 2023 - 23 April 2023
,2023, 'Strength in solidarity: Bringing together diverse local stakeholders to disseminate public drug information (presented on behalf of the Prompt Response Network)', presented at Harm Reduction International, Melbourne, Australia, 16 April 2023 - 19 April 2023, https://hr23.hri.global/programme/
,2022, 'Feasibility and efficacy of the S-Check App to change help seeking behaviour of people who use methamphetamine', presented at Lisbon Addictions, Lisbon, Portugal, 23 November 2022 - 25 November 2022
,2022, 'Safety and tolerability of lisdexamfetamine for methamphetamine dependence and withdrawal, early experience from Australia: The LiMA Trial and OLAM pilot', presented at Annual Meeting Conference of the Norwegian Association for Addiction Medicine, Bergen, Norway, 02 November 2022
,Conference Abstracts
2023, 'Oral naltrexone-bupropion combination pharmacotherapy for methamphetamine use disorder: Pilot study protocol', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
,2022, 'The AusMAP study: A protocol for a randomised, controlled feasibility study of a managed alcohol program in Australia', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S44 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'OPTIMISING CARE FOR PEOPLE WHO INJECT DRUGS: A RETROSPECTIVE MEDICAL RECORD REVIEW OF STAPHYLOCOCCUS AUREUS BACTERAEMIA TREATMENT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'COGNITIVE EFFECTS OF ESCALATING DOSES OF ORAL LISDEXAMFETAMINE IN METHAMPHETAMINE DEPENDENT ADULTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'DEVELOPMENT OF THE SUBSTANCE USE SEX INDEX - A NEW TOOL FOR BEHAVIOUR CHANGE MEASUREMENT IN DRUG TREATMENT STUDIES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'BARRIERS TO STIMULANT TREATMENT ACCESS FOR WOMEN WHO USE METHAMPHETAMINE IN INNER SYDNEY: A QUALITATIVE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 71 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,